EUVIMEDEUVIMED entdecken
Crossref

Early Changes in Composite Insulin-Resistance Indices After Adjunctive Probiotic Treatment in Olanzapine-Treated Schizophrenia: A Longitudinal Secondary Analysis

Cuiping Luo, Guangwei Qing, Jing Zhang, Hongfei Wan, Simin Xiong, Yuxin Zhou, Kun Yan, Yongzhi Xiong

The International Journal of Psychiatry in Medicine · 14.08.2026

DOI: 10.1177/00912174261474760 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The International Journal of Psychiatry in Medicine, online erschienen am 14.08.2026. Verfasst von Cuiping Luo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Jiangxi Mental Hospital & Affiliated Mental Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China. Die Arbeit nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Olanzapine is effective for schizophrenia but commonly causes metabolic dysregulation. This study examined whether adjunctive probiotic treatment was associated with short-term changes in composite insulin-resistance-related indices during olanzapine therapy.

Methods

This longitudinal secondary analysis included 84 patients with schizophrenia receiving olanzapine: 40 received adjunctive Bifidobacterium tetravaccine live tablets and 44 received olanzapine alone. The triglyceride-glucose index (TyG), triglyceride-glucose–body mass index (TyG-BMI), metabolic score for insulin resistance (METS-IR), single-point insulin sensitivity estimator (SPISE), and triglyceride-to-high-density lipoprotein cholesterol ratio (TG/HDL-C) were assessed at baseline, Week 2, and Week 4. Baseline-adjusted linear mixed-effects models evaluated group × visit interactions and visit-specific contrasts. False discovery rate (FDR) correction and sensitivity analyses were applied.

Results

Significant group × visit interactions were observed for TyG-BMI ( P < 0.001; FDR

Schlagwörter

Stichwörter der Autor:innen

Bifidobacterium tetravaccineTyG-BMIinsulin resistanceolanzapineprobioticsschizophrenia

Autor:innen und Institutionen

  • Jiangxi Mental Hospital & Affiliated Mental Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
  • Nanchang City Key Laboratory of Biological Psychiatry, Jiangxi Provincial Health Commission Key Laboratory of Psychiatry, Jiangxi Provincial Clinical Research Center on Mental Disorders, Jiangxi Mental Hospital, Nanchan…
  • Beijing Key Laboratory of Intelligent Drug Research and Development for Mental Disorders; National Clinical Research Center for Mental Disorders; National Center for Mental Disorders, Beijing Anding Hospital Capital Med…

Zitieren

APA

Luo, C., Qing, G., Zhang, J., Wan, H., Xiong, S., Zhou, Y., Yan, K., & Xiong, Y. (2026). Early Changes in Composite Insulin-Resistance Indices After Adjunctive Probiotic Treatment in Olanzapine-Treated Schizophrenia: A Longitudinal Secondary Analysis. The International Journal of Psychiatry in Medicine. https://doi.org/10.1177/00912174261474760

Vancouver

Luo C, Qing G, Zhang J, Wan H, Xiong S, Zhou Y, et al. Early Changes in Composite Insulin-Resistance Indices After Adjunctive Probiotic Treatment in Olanzapine-Treated Schizophrenia: A Longitudinal Secondary Analysis. The International Journal of Psychiatry in Medicine. 2026. doi:10.1177/00912174261474760

BibTeX
@article{Luo2026,
  author = {Luo, Cuiping and Qing, Guangwei and Zhang, Jing and Wan, Hongfei and Xiong, Simin and Zhou, Yuxin and Yan, Kun and Xiong, Yongzhi},
  title = {Early Changes in Composite Insulin-Resistance Indices After Adjunctive Probiotic Treatment in Olanzapine-Treated Schizophrenia: A Longitudinal Secondary Analysis},
  journal = {The International Journal of Psychiatry in Medicine},
  year = {2026},
  doi = {10.1177/00912174261474760}
}
Kostenlos starten →